Meditation-based clinical study for correlation study of quantitative EEG and 24 hours activity electrocardiogram

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003012

Enrollment

Registered

2018-07-21

Start date

2018-07-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This clinical research is conducted with subjects who voluntarily submitted to a consent and were reviewed according to the inclusion or exclusion criteria of the clinical trial plan.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) age over 20 years below 45 years 2) Does not indulge in smoking, tea or coffee, has regular diet and a normal sleeping pattern. 3) right-handed. 4) Were informed of the purpose and process of this clinical trial and voluntarily consented to it

Exclusion criteria

Exclusion criteria: 1) Who has arrhythmia on EKG, or the pulse rate per minute is out of the range of 50-100 2) Who has a severe physical illness or medically unstable (Decided by the clinical trial conducter or medical expert. 3) Who has a congenital illness, psychological illness , central nervous problem , peripheral nervous problem, endocrinal illness, immunodisease, basal heart disease, liver disease, renal disease. 4) Who has a neurological illness such as head trauma or psychological history such as major depressive disorder, anxiety disorder, bipolar disorder, schizophrenia. 5) Who has pace maker, stimulation brain devices, ventriculo-peritoneal shunt or artificial organ. 6) Who takes medicines that may affect the autonomic nervous system within one week before the enrollment in clinical trials.(example: opiates, stimulants, tricyclic antidepressants, benzodiazepines, and cardiac drugs such as beta-blockers, renin-angiotension-alcosternone system blockers such as angiotensin-converting enzyme inhibiotrs and angiotensin receptor blockers) 7)Who smokes, takes alcohol or caffeine contained products since at least 2 hours before the clinical trial.(example: Coffee, coffee milk, Black tea, Green tea, cocoa, coke, chocolate, caffeine contained energy drinks. 8)Who is pregnant or breast feeding 9)Who participated in other clinical study for the past one month or is participating in other clinical studies currently. 10) Who is difficult to participate in this study judged by investigator.

Design outcomes

Primary

Measure	Time frame
Quantative electroencephalogram;24-hours activity electrocardiogram	—

Secondary

Measure	Time frame
Preclinic Phase(=Mibyung) Questionnaire;Constitutional Questionnaire;Psychosocial Wellbeing Index Short Form;Hospital Anxiety and Depression Scale;Korean Sex Role Inventory-Short Form;Five Facet Mindfulness Questionnaire-Short scale;Korean version of the Positive Affect and Negative Affect Schedule;The Core Seven Emotions Inventory	—

Countries

Korea, Republic of

Contacts

Public ContactSungeun Sohn

Wonkwang University

kno1mj@naver.com+82-63-270-1021

Outcome results